Skip to main content
Equibles

Bettina Cockroft

Board Member

CNS Pharmaceuticals, Inc. (CNSP)

Equibles does not estimate personal net worth.

Get an email with a short summary when CNS Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get CNSP alerts

About Bettina Cockroft

Bettina Cockroft is recorded as Board Member at CNS Pharmaceuticals, Inc. (CNSP). The newest filing on record that lists Bettina Cockroft as Board Member at CNS Pharmaceuticals, Inc. (CNSP) is dated August 21, 2026. CNS Pharmaceuticals, Inc. reported in an 8-K filed October 2, 2026 that Bettina Cockroft was appointed director, effective September 30, 2026. CNS Pharmaceuticals, Inc. reported in an 8-K filed November 21, 2025 that Bettina Cockroft was appointed Director, effective November 17, 2025. CNS Pharmaceuticals, Inc. reported in an 8-K filed May 3, 2024 that Bettina Cockroft was appointed Director, effective April 30, 2024. Equibles holds 4 filed executive changes naming Bettina Cockroft; each is listed under recent activity with its source filing. CNS Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CNS Pharmaceuticals, Inc. includes Rami Levin (CEO and Board Member), Faith Charles (Chairman and Board Member), Steve O'Loughlin (CFO) and 7 others.

“The Company's stockholders elected Faith Charles, Bettina Cockroft, Michal Fisher, Jeffrey Keyes, Rami Levin and Amy Mahery, as directors of the Company until the Company's 2027 Annual Meeting of Stockholders, or until their respective successors have been duly elected and qualified, by the following vote:”
CNS Pharmaceuticals, Inc. Form 8-K, filed October 2, 2026 · Read the filing
“The Company's stockholders elected John Climaco, Jerzy (George) Gumulka, Jeffry R. Keyes, Faith Charles, Bettina Cockroft, and Amy Mahery, each to serve until the 2026 Annual Meeting of Stockholders or until such person's successor is qualified and elected, by the following vote:”
CNS Pharmaceuticals, Inc. Form 8-K, filed November 21, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at CNS Pharmaceuticals, Inc.

Recent activity